These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
450 related items for PubMed ID: 19421200
1. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. Maisels MJ, Deridder JM, Kring EA, Balasubramaniam M. J Perinatol; 2009 Sep; 29(9):612-7. PubMed ID: 19421200 [Abstract] [Full Text] [Related]
3. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, Meloy L, Burgos AE, Hall JY, Stevenson DK, Initial Clinical Testing Evaluation and Risk Assessment for Universal Screening for Hyperbilirubinemia Study Group. J Pediatr; 2013 Mar; 162(3):477-482.e1. PubMed ID: 23043681 [Abstract] [Full Text] [Related]
4. Prediction of severe hyperbilirubinaemia using the Bilicheck transcutaneous bilirubinometer. Boo NY, Ishak S. J Paediatr Child Health; 2007 Apr; 43(4):297-302. PubMed ID: 17444833 [Abstract] [Full Text] [Related]
5. Does measuring the changes in TcB value offer better prediction of Hyperbilirubinemia in healthy neonates? Dalal SS, Mishra S, Agarwal R, Deorari AK, Paul V. Pediatrics; 2009 Nov; 124(5):e851-7. PubMed ID: 19822593 [Abstract] [Full Text] [Related]
6. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536 [Abstract] [Full Text] [Related]
12. Visual screening versus transcutaneous bilirubinometry for predischarge jaundice assessment. Kaplan M, Shchors I, Algur N, Bromiker R, Schimmel MS, Hammerman C. Acta Paediatr; 2008 Jun; 97(6):759-63. PubMed ID: 18460107 [Abstract] [Full Text] [Related]
13. Clinical implication of the difference between transcutaneous bilirubinometry and total serum bilirubin for the classification of newborns at risk of hyperbilirubinemia. Rodríguez-Capote K, Kim K, Paes B, Turner D, Grey V. Clin Biochem; 2009 Feb; 42(3):176-9. PubMed ID: 18929552 [Abstract] [Full Text] [Related]
14. Prediction of hyperbilirubinemia in near-term and term infants. Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ, MacMahon JR, Yeung CY, Seidman DS, Gale R, Oh W, Bhutani VK, Johnson LH, Kaplan M, Hammerman C, Nakamura H. J Perinatol; 2001 Dec; 21 Suppl 1():S63-72; discussion S83-7. PubMed ID: 11803421 [Abstract] [Full Text] [Related]
17. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Pediatrics; 2000 Aug; 106(2):E17. PubMed ID: 10920173 [Abstract] [Full Text] [Related]